The SMAC mimetic GDC-0152 is a direct ABCB1-ATPase activity modulator and BIRC5 expression suppressor in cancer cells
Article in Toxicology and Applied Pharmacology (March 2024)
The most recent citing publications are shown below. View all 16 publications that cite this research output on Dimensions.
Article in Toxicology and Applied Pharmacology (March 2024)
Article in The Cancer Journal (September 2022)
Article in International Journal of Molecular Medicine (June 2022)